Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details) - Schedule of stock-based compensation expense

v3.22.2.2
Shareholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Total stock-based compensation expense $ 557,015 $ 1,188,877 $ 2,640,349 $ 3,356,859
Research and Development Options Expense [Member]        
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Total stock-based compensation expense 51,799 79,604 180,627 223,413
Total research and development expenses [Member]        
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Total stock-based compensation expense 51,799 79,604 180,627 223,413
General and Administrative Options Expense [Member]        
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Total stock-based compensation expense 426,069 468,281 1,490,246 1,289,192
Stock and Warrants Issued to Consultants and Employees [Member]        
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Total stock-based compensation expense 79,147 640,992 969,476 1,844,254
Total General and Administrative Expenses [Member]        
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Total stock-based compensation expense $ 505,216 $ 1,109,273 $ 2,459,722 $ 3,133,446